Amplifications of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction

Breast Cancer Research and Treatment

Volumn 40, Issue 3, 1996, Pages 271-281

  Deng, Guoren ^a   Yu, Mei ^a   Chen, Ling Chun ^a   Moore, Dan ^a   Kurisu, Wayne ^a   Kallioniemi, Anne ^b,c   Waldman, Frederick M ^b   Collins, Colin ^d   Smith, Helene S ^a,e  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^e Geraldine Brush Cancer Res Inst   (United States)

Author keywords

Amplicon; Breast cancer; Chromosome; Gene amplification; Polymerase chain reaction

Indexed keywords

DNA;

ADULT; ARTICLE; BREAST CANCER; CHROMOSOME 20Q; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; ONCOGENE NEU; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SLOT BLOT ANALYSIS; SOUTHERN BLOTTING;

BLOTTING, SOUTHERN; BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 20; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENES, ERBB-2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0029814018     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806816     Document Type: Article

References (39)

1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987
2. Machotka SV, Garret CT, Schwartz AM, Callahan R: Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer. Clin Chim Acta 184: 207-218, 1989
3. Lammie GA, Peters G: Chromosome 11q13 abnormalities in human cancer. Cancer Cells 3: 413-420, 1991
4. Adnane J, Gaudray P, Dionne CA, Crumley G, Jaye M, Schlessinger J, Jeanteur P, Birnbaum D, Theillet C: BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 6: 659-663, 1991
5. Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkoski M, Akita R, Paterson MC, Slamon DJ: Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res 53: 4960-4970, 1993
6. Hynes NE: Amplification and overexpresssion of the erbB-2 gene in human tumors: Its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy. Sem Cancer Biol 4: 19-26, 1993
7. Tripathy D, Benz C: Activated oncogenes and putative tumor suppressor genes involved in human breast cancers. Cancer Treat Res 63: 15-60, 1992
8. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer correlation of relapse and survival with amplification for the HER-2/enu oncogene. Science 235: 177-182, 1987
9. Varley JM, Swallow JE, Brammar WJ, Whittaker JL, Walker RA: Alterations to either c-erb B-2 (neu) or c-myc protooncogene in breast carcinomas correlate with poor short-term prognosis. Oncogene 1: 423-430, 1987
10. Lidereau R, Callahan R, Dickson C, Peters G, Escot C, Ali I: Amplification of the int-2 gene in primary human breast tumors. Oncogene Res 2: 285-291, 1988
11. Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S, Yamamoto H, Miyajima N, Toyoshima K, Yamamoto T, Yokota J, Yoshida T, Sakamoto H, Terada M, Sugimura T: Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units; hst-1/int-2 and c-erbB-2/ear-1. Cancer Res 49: 3104-3108, 1989
12. Borg A, Sigurdsson H, Clark GM, Ferno M, Fuqua SAW, Olsson H, Kilander D, McGuire WL: Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br J Cancer 63: 136-142, 1991
13. Schurring E, Verhoeven E, van Tinteren H, Peterse JL, Nunnink B, Thunnissen FB, Devilee P, Cornelisse CJ, van de Vijver MJ, Mooi WJ: Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 52: 229-234, 1992
14. Shiu RP, Watson PH, Dubik D: c-myc oncogene expression in estrogen-dependent and independent breast cancer. Clin Chem 39: 353-355, 1993
15. Borg A, Baldetorp B, Ferno M, Olsson H, Sigurdsson H: c-myc amplification is an independent prognostic factor in postmenopausal breast cancer. Int J Cancer 51: 687-691, 1992
16. Berns EM, Foekens JA, van Putten WL, van Staveren IL, Portengen H, de Koning WC, Klijn JG: Prognostic factors in human primary breast cancer: comparison of c-myc and HER2/neu amplification. J Steroid Biochem Mol Biol 43: 13-19, 1992
17. Roux-Dosseto M, Romain S, Dussault N, Desideri C, Piana L, Bonnier P, Tubiana N, Martin PM: c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse. Eur J Cancer 28A: 1600-1604, 1992
18. Berns EM, Klijn JG, van Putten WL, van Staveren IL: c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer. Cancer Res 52: 1107-1113, 1992
19. Kallioniemi A, Kallioniemi O-P, Piper J, Chen L, Smith HS, Gray JW, Pinkel D, Waldman FW: Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 91: 2156-2160, 1994
20. Chelly J, Kaplan J-C, Maire P, Gautron S, Kahn A: Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 333: 858-860, 1988
21. Frye RA, Benz CC, Liu E: Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene 4: 1153-1157, 1989
22. Lonn U, Lonn S, Nylen U, Friberg S, Stenkvist B: Gene amplification detected in carcinoma cells from human urinary bladder washings by the polymerase chain reaction method. Cancer 71: 3605-3610, 1993
23. Gilliland G, Perrin S, Planchard K, Bunn HF: Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 87: 2725-2729, 1990
24. Uberla K, Platzer C, Diamantstein T, Blankenstein T: Generation of competitor DNA fragments for quantitative PCR. PCR Methods Appl 1: 136-139, 1991
25. Siebert PD, Larrick JW: Competitive PCR. Nature 359: 557-558, 1992
26. Siebert PD, Larrick JW: PCR MIMICS: competitive DNA fragments for use as internal standard in quantitation PCR. Biotechniques 14: 244-249, 1993
27. Deng G, Yu M, Smith HS: An improved method of competitive PCR for quantitation of gene copy number. Nucl Acids Res 21: 4848-4849, 1993
28. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning: a laboratory manual. Cold Spring Harbor Lab, Cold Spring Harbor, New York, 1989, pp 16-19
29. King CR, Kraus MH, Aaronson SA: Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229: 974-976, 1985
30. Hudson TJ, Engelstein M, Lee MK, Ho EC, Rubenfield MJ, Adams CP, Housman DE: Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms. Genomics 13: 622-629, 1992
31. Deng G, Liu G, Hu L, Gum JR, Kim YS: Transcriptional regulation of the human placental-like alkaline phosphatase gene and mechanisms involved in its induction by sodium butyrate. Cancer Res 52: 3378-3383, 1992
32. Hazon J, Dubay C, Pankowiak MP, Becuwe N, Weissenbach J: A genetic linkage map of human chromosome 20 composed entirely of microsatellite markers. Genomics 12: 183-189, 1992
33. Granqvist M, Xiang KS, Seino M, Bell GI: Dinucleotide repeal polymorphism in GsNa subunit gene (GNAS1) on chromosome 20. Nucleic Acids Res 19: 4569, 1991
34. Bloch KD, Eddy RL, Shows TB, Quertermous T: cDNA cloning and chromosomal assignment of the gene encoding endothelin 3. J Biol Chem 264: 18156-18161, 1989
35. Polymeropoulos MH, Xiao H, Rath DS, Merril CR: Dinucleotide repeat polymorphism at the human cysteine-proteinase inhibitor pseudogene (CSTP1). Nucleic Acids Res 19:1164, 1991
36. Deng G, Chen L-C, Schott DR, Thor A, Bhargava V, Ljung B-M, Chew K, Smith HS: Loss of heterozygosity and p53 gene mutations in breast cancer. Cancer Res 54: 499-505, 1994
37. Kallioniemi O-P, Kallioniemi A, Kurisu W, Thor A, Chen L-C, Smith HS, Waldman FM, Pinkel D, Gray JW: ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89: 5321-5325, 1992
38. NIH/CEPH Collaborative Mapping Group: A comprehensive genetic linkage map of the human genome. Science 258: 67-86, 1992
39. Tanner M, Tirkkonen M, Kallioniemi A, Collins C, Stokke T, Karhu R, Kowbel D, Shadravan F, Hintz M, Kuo W-L, Waldman FM, Isola J, Gray JW, Kallioniemi OP: Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res 54: 4257-4260, 1994